Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Change in Acquisitions & Divestments (2023 - 2026)

Rallybio's Change in Acquisitions & Divestments history spans 3 years, with the latest figure at $11.0 million for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 30.16% to $11.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $46.5 million, a 44.96% decrease, with the full-year FY2025 number at $46.5 million, down 44.96% from a year prior.
  • Change in Acquisitions & Divestments hit $11.0 million in Q4 2025 for Rallybio, up from $10.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for RLYB hit a ceiling of $38.5 million in Q2 2023 and a floor of $7.5 million in Q2 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $22.4 million across 3 years, with a median of $22.1 million in 2024.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 17.24% in 2025, down 66.67% in 2025.
  • Tracing RLYB's Change in Acquisitions & Divestments over 3 years: stood at $30.4 million in 2023, then crashed by 48.2% to $15.8 million in 2024, then plummeted by 30.16% to $11.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for RLYB at $11.0 million in Q4 2025, $10.0 million in Q3 2025, and $7.5 million in Q2 2025.